Recommendations for inclusion in the Authorisation List
Recommendations for inclusion in the Authorisation List
Nested Applications
The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV (the "Authorisation List") to the European Commission, taking into account comments received from interested parties and the opinion of the Member State Committee. The European Commission finally decides, which substances will be included in Annex XIV and what the associated entries will be.
The below table includes all Candidate List substances that have been included in ECHA's draft or final recommendations for inclusion in Annex XIV. The "Status"- column indicates whether the substances have been included in a draft recommendation, recommended for inclusion or are already included in Annex XIV. Further details and documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.
Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds along with the other substances on the Candidate List. They may be included in future recommendations. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
- Consultation on draft recommendation for inclusion in the Authorisation List
- MSC recommendation opinions
- Recommendation for inclusion in the Authorisation List under the Legislation section
- Authorisation Process
- Recommendation to amend authorisation list entries
- Candidate List of SVHCs for authorisation
- Authorisation List
Recommendations for inclusion in the Authorisation List
Last updated 20 listopada 2023. Database contains 111 unique substances/entries.
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
show/hide
|
799-970-2
|
-
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
203-468-6
|
107-15-3
|
Respiratory sensitising properties (Article 57(f) - human health) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
203-856-5
|
111-30-8
|
Respiratory sensitising properties (Article 57(f) - human health) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
231-100-4
|
7439-92-1
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
show/hide
|
799-969-7
|
-
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details |
276-090-2
|
71850-09-4
|
Toxic for reproduction (Article 57c) |
11th recommendation
|
Recommended for inclusion in Annex XIV
|
12-tra-2023
|
Details | |
208-762-8
|
540-97-6
|
PBT (Article 57d) vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
208-764-9
|
541-02-6
|
PBT (Article 57d) vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
209-136-7
|
556-67-2
|
PBT (Article 57d) vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
234-541-0
|
12008-41-2
|
Toxic for reproduction (Article 57c) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
209-008-0
|
552-30-7
|
Respiratory sensitising properties (Article 57(f) - human health) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
201-545-9
|
84-61-7
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
262-967-7
|
61788-32-7
|
vPvB (Article 57e) |
10th recommendation
|
Recommended for inclusion in Annex XIV
|
14-tra-2021
|
Details | |
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC No.:
-
| CAS No.:
135821-03-3
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EC No.:
236-948-9
| CAS No.:
13560-89-9
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EC No.:
-
| CAS No.:
135821-74-8
|
-
|
-
|
vPvB (Article 57e) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details |
209-218-2
|
561-41-1
|
Carcinogenic (Article 57a) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
201-245-8
|
80-05-7
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
EC No.:
939-460-0
| CAS No.:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
EC No.:
300-298-5
| CAS No.:
93925-00-9
|
-
|
-
|
Endocrine disrupting properties (Article 57(f) - environment) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details |
915-270-3
|
-
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
239-622-4
|
15571-58-1
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
273-688-5
|
69011-06-9
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
235-702-8
|
12578-12-0
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
292-966-7
|
91031-62-8
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
234-853-7
|
12036-76-9
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
263-467-1
|
62229-08-7
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
201-075-4
|
78-00-2
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lis-2019
|
Details | |
215-290-6
|
1319-46-6
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
235-252-2
|
12141-20-7
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details |
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details |
203-713-7
|
109-86-4
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
203-804-1
|
110-80-5
|
Toxic for reproduction (Article 57c) |
9th recommendation
|
Recommended for inclusion in Annex XIV
|
01-lis-2019
|
Details | |
253-037-1
|
36437-37-3
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
247-384-8
|
25973-55-1
|
PBT (Article 57d) vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
223-383-8
|
3864-99-1
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
223-346-6
|
3846-71-7
|
PBT (Article 57d) vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details | |
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
EC No.:
413-720-9
| CAS No.:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
601-499-3
| CAS No.:
117933-89-8
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
-
| CAS No.:
186309-28-4
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
EC No.:
-
| CAS No.:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
EC No.:
-
| CAS No.:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-02-5
|
-
|
-
|
vPvB (Article 57e) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details |
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
EC No.:
272-013-1
| CAS No.:
68648-93-1
|
-
|
-
|
Toxic for reproduction (Article 57c) |
8th recommendation
|
Included in Annex XIV (Authorisation List)
|
05-velj-2018
|
Details |
212-828-1
|
872-50-4
|
Toxic for reproduction (Article 57c) |
8th recommendation
|
Recommended for inclusion in Annex XIV
|
05-velj-2018
|
Details | |
235-380-9
|
12202-17-4
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
235-067-7
|
12065-90-6
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
215-235-6
|
1314-41-6
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
215-267-0
|
1317-36-8
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Recommended for inclusion in Annex XIV
|
10-stu-2016
|
Details | |
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
7th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
10-stu-2016
|
Details |
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
Respiratory sensitising properties (Article 57(f) - human health) |
7th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
10-stu-2016
|
Details |
271-093-5
|
68515-50-4
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details | |
201-559-5
|
84-75-3
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details | |
246-677-8
|
25155-23-1
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details | |
show/hide
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)
EC No.:
-
| CAS No.:
125022-34-6
|
-
|
-
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details |
231-556-4
|
7632-04-4
|
Toxic for reproduction (Article 57c) |
7th recommendation
|
Included in Annex XIV (Authorisation List)
|
10-stu-2016
|
Details | |
257-175-3
|
51404-69-4
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
01-srp-2015
|
Details | |
215-267-0
|
1317-36-8
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
01-srp-2015
|
Details | |
215-235-6
|
1314-41-6
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
01-srp-2015
|
Details | |
235-067-7
|
12065-90-6
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
01-srp-2015
|
Details | |
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77588.
|
232-382-1
|
8012-00-8
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
01-srp-2015
|
Details |
234-363-3
|
11120-22-2
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
01-srp-2015
|
Details | |
235-380-9
|
12202-17-4
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
01-srp-2015
|
Details | |
215-540-4
|
1330-43-4
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Recommended for inclusion in Annex XIV
|
01-srp-2015
|
Details | |
235-541-3
|
12267-73-1
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Recommended for inclusion in Annex XIV
|
01-srp-2015
|
Details | |
215-125-8
|
1303-86-2
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Recommended for inclusion in Annex XIV
|
01-srp-2015
|
Details | |
EC No. 233-139-2 and EC No. 234-343-4
show/hide
|
-
|
-
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Recommended for inclusion in Annex XIV
|
01-srp-2015
|
Details |
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
show/hide
26-(4-Nonylphenoxy)-3,6,9,12,15,18,21,24- octaoxahexacosan -1-ol
EC No.:
604-395-6
| CAS No.:
14409-72-4
Poly (oxy-1,2-ethanediyl), alpha -(nonylphenyl)-omega-hydroxy-, branched
EC No.:
932-337-2
| CAS No.:
-
Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EC No.:
500-209-1
| CAS No.:
68412-54-4
3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-, branched
EC No.:
293-926-1
| CAS No.:
91648-64-5
3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)-
EC No.:
-
| CAS No.:
65455-72-3
4-Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EC No.:
500-315-8
| CAS No.:
127087-87-0
44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol
EC No.:
260-678-0
| CAS No.:
57321-10-5
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
EC No.:
255-695-5
| CAS No.:
42173-90-0
29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol
EC No.:
248-294-1
| CAS No.:
27177-08-8
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
EC No.:
247-816-5
| CAS No.:
26571-11-9
|
-
|
-
|
Endocrine disrupting properties (Article 57(f) - environment) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details |
203-445-0
|
106-94-5
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300°C to 400°C (572°F to 752°F). Composed primarily of phenanthrene, anthracene and carbazole
|
292-602-7
|
90640-80-5
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details |
The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30°C to 180°C (86°F to 356°F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.
|
266-028-2
|
65996-93-2
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details |
933-378-9
|
776297-69-9
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
205-017-9
|
131-18-0
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
210-088-4
|
605-50-5
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
204-212-6
|
117-82-8
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
284-032-2
|
84777-06-0
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
271-084-6
|
68515-42-4
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
276-158-1
|
71888-89-6
|
Toxic for reproduction (Article 57c) |
6th recommendation
|
Included in Annex XIV (Authorisation List)
|
01-srp-2015
|
Details | |
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
Carcinogenic (Article 57a) |
5th recommendation
|
Recommended for inclusion in Annex XIV
|
06-velj-2014
|
Details |
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium, silicon and zirconium are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm). c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
Carcinogenic (Article 57a) |
5th recommendation
|
Recommended for inclusion in Annex XIV
|
06-velj-2014
|
Details |
200-679-5
|
68-12-2
|
Toxic for reproduction (Article 57c) |
5th recommendation
|
Recommended for inclusion in Annex XIV
|
06-velj-2014
|
Details | |
204-650-8
|
123-77-3
|
Respiratory sensitising properties (Article 57(f) - human health) |
5th recommendation
|
Recommended for inclusion in Annex XIV
|
06-velj-2014
|
Details | |
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
EC No.:
618-541-1
| CAS No.:
9036-19-5
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
EC No.:
219-682-8
| CAS No.:
2497-59-8
|
-
|
-
|
Endocrine disrupting properties (Article 57(f) - environment) |
5th recommendation
|
Included in Annex XIV (Authorisation List)
|
06-velj-2014
|
Details |
214-604-9
|
1163-19-5
|
PBT (Article 57d) vPvB (Article 57e) |
5th recommendation
|
Not recommended for inclusion in Annex XIV - to be re-assessed in following round
|
06-velj-2014
|
Details | |
500-036-1
|
25214-70-4
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
204-826-4
|
127-19-5
|
Toxic for reproduction (Article 57c) |
4th recommendation
|
Recommended for inclusion in Annex XIV
|
17-sij-2013
|
Details | |
203-924-4
|
111-96-6
|
Toxic for reproduction (Article 57c) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
203-458-1
|
107-06-2
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
202-918-9
|
101-14-4
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
231-901-9
|
7778-39-4
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
256-418-0
|
49663-84-5
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
234-329-8
|
11103-86-9
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
232-142-6
|
7789-06-2
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
246-356-2
|
24613-89-6
|
Carcinogenic (Article 57a) |
4th recommendation
|
Included in Annex XIV (Authorisation List)
|
17-sij-2013
|
Details | |
201-167-4
|
79-01-6
|
Carcinogenic (Article 57a) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details | |
234-190-3
|
10588-01-9
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details | |
231-889-5
|
7775-11-3
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details | |
231-906-6
|
7778-50-9
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details | |
232-140-5
|
7789-00-6
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details | |
232-143-1
|
7789-09-5
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details | |
show/hide
|
-
|
-
|
Carcinogenic (Article 57a) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details |
215-607-8
|
1333-82-0
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
3rd recommendation
|
Included in Annex XIV (Authorisation List)
|
20-pro-2011
|
Details | |
233-334-2
|
10124-43-3
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Recommended for inclusion in Annex XIV
|
20-pro-2011
|
Details | |
233-402-1
|
10141-05-6
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Recommended for inclusion in Annex XIV
|
20-pro-2011
|
Details | |
200-755-8
|
71-48-7
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Recommended for inclusion in Annex XIV
|
20-pro-2011
|
Details | |
231-589-4
|
7646-79-9
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Recommended for inclusion in Annex XIV
|
20-pro-2011
|
Details | |
208-169-4
|
513-79-1
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
3rd recommendation
|
Recommended for inclusion in Annex XIV
|
20-pro-2011
|
Details | |
204-450-0
|
121-14-2
|
Carcinogenic (Article 57a) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details | |
215-116-9
|
1303-28-2
|
Carcinogenic (Article 57a) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details | |
215-481-4
|
1327-53-3
|
Carcinogenic (Article 57a) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details | |
201-553-2
|
84-69-5
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
2nd recommendation (2010), amendment recommendation (2019)
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details | |
231-846-0
|
7758-97-6
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details | |
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.
|
235-759-9
|
12656-85-8
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details |
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.
|
215-693-7
|
1344-37-2
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details |
204-118-5
|
115-96-8
|
Toxic for reproduction (Article 57c) |
2nd recommendation
|
Included in Annex XIV (Authorisation List)
|
17-pro-2010
|
Details | |
287-476-5
|
85535-84-8
|
PBT (Article 57d) vPvB (Article 57e) |
1st recommendation
|
Recommended for inclusion in Annex XIV
|
01-lip-2009
|
Details | |
201-557-4
|
84-74-2
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
1st recommendation (2009), amendment recommendation (2019)
|
Included in Annex XIV (Authorisation List)
|
01-lip-2009
|
Details | |
201-622-7
|
85-68-7
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
1st recommendation (2009), amendment recommendation (2019)
|
Included in Annex XIV (Authorisation List)
|
01-lip-2009
|
Details | |
204-211-0
|
117-81-7
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
1st recommendation (2009), amendment recommendation (2019)
|
Included in Annex XIV (Authorisation List)
|
01-lip-2009
|
Details | |
and all major diastereoisomers identified
show/hide
|
-
|
-
|
PBT (Article 57d) |
1st recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lip-2009
|
Details |
202-974-4
|
101-77-9
|
Carcinogenic (Article 57a) |
1st recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lip-2009
|
Details | |
201-329-4
|
81-15-2
|
vPvB (Article 57e) |
1st recommendation
|
Included in Annex XIV (Authorisation List)
|
01-lip-2009
|
Details | |